ROUNDUP/Aktien New York Schluss: Wenig Dynamik vor langem Wochenende

RXi Pharmaceuticals Corporation Discusses Competitive Advantage, Goals and Milestones for 2016-2017 in New SNNLive Newscast on

Montag, 28.11.2016 14:30 von PR Newswire

PR Newswire

LOS ANGELES, Nov. 28, 2016 /PRNewswire/ --, The Official MicroCap News Source™, today published an SNNLive Newscast with Pamela Pavco, Ph.D., Chief Development Officer for RXi Pharmaceuticals Corporation (NASDAQ: RXII) a clinical-stage company developing therapeutics that address unmet medical needs, according to the company's website (see here: The video interview was recorded on Monday, November 14th, 2016 via Skype from SNN's office in Los Angeles, CA and RXi's headquarters in Marlborough, MA.

Click the following link to watch the SNNLive Newscast™ Video Interview on

Update with RXi Pharmaceuticals Corporation – Competitive Advantage, Goals and Milestones for 2016-2017


Please review important disclosures on our website at:

About RXi Pharmaceuticals Corporation

RXi Pharmaceuticals Corporation (NASDAQ: RXII) is a clinical-stage company developing innovative therapeutics that address significant unmet medical needs.  Building on the pioneering discovery of RNAi, the Company's discovery and clinical development programs are based on its proprietary self-delivering RNAi (sd-rxRNA®) platform and Samcyprone™, a small molecule topical immunomodulator. Current clinical development programs include RXI-109, an sd-rxRNA, for the treatment of dermal and ocular scarring, and Samcyprone™ for the treatment of such disorders as warts, alopecia areata, non-malignant skin tumors and cutaneous metastases of melanoma.  RXi's robust pipeline, coupled with an extensive patent portfolio, provides for multiple product and business development opportunities across a broad spectrum of therapeutic areas. We are committed to being a partner of choice for academia, small companies, and large multinationals. We welcome ideas and proposals for strategic alliances, including in- and out-licensing opportunities, to advance and further develop strategic areas of interest. For company description and additional information may be found on the Company's website,

About is a microcap financial news portal that features news and insights from the microcap and emerging growth financial community. is a multimedia destination hub for information about microcap and emerging growth public and private companies, market events, news, bulletins, stock quotes, expert commentary and company profiles that feature SNN-produced video like SNNLive CEO video interviews, as well as their latest news and headlines. Users can engage directly and share the information provided through social media.

Follow the companies YOU want to know more about; read and watch content from YOUR favorite microcap, emerging growth financial experts; register to attend financial conferences of YOUR choosing; find microcap and emerging growth financial professionals that YOU may be looking for - all here on


To view the original version on PR Newswire, visit: